Association of SORL1 polymorphisms and SORL1-APOE ε4 interaction with risk of subjective cognitive decline and mild cognitive impairment in the Chinese population
Journal of Alzheimer’s Disease · 2026-06 · 111 (3) · 1180-1191
DOI: 10.1177/13872877261441644 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 17.04.2026. Verfasst von Fanfan Meng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Apolipoprotein E4, Cognitive Dysfunction, LDL-Receptor Related Proteins, Membrane Transport Proteins. Die Arbeit nennt 34 Literaturangaben. Gefördert von: National Key R&D Program of China, Science & Technology Department of Jiangsu Province.
Abstract (Originalsprache)
Background
Alzheimer's disease (AD) is a multifactorial disorder. The sortilin-related receptor 1 ( SORL1 ) gene, which regulates the trafficking and recycling of amyloid precursor protein, has been reported to be associated with the development of AD.
Objective
This study investigated the impact of SORL1 polymorphisms (rs641120 and rs1784933) and their interaction with the apolipoprotein E ( APOE ) ε4 allele on AD preclinical stages—subjective cognitive decline (SCD) and mild cognitive impairment (MCI). We also explored the association between the rs641120 and serum biomarkers.
Methods
The study included 225 SCD, 131 MCI, and 62 normal controls (NC). Logistic regression models were utilized to assess genetic risks and interactions. Nonparametric tests or t-tests were employed to examine group differences stratified by protective genes in neuropsychological performance and biomarkers.
Results
The rs641120 A allele was associated with a lower risk of SCD and MCI, within AA genotype (OR = 0.575) and AG genotype (OR = 0.588). In MCI patients, the A allele was associated with lower levels of serum Aβ 1−42 and p-tau181. An interaction between SORL1 rs1784933 and the APOE ε4 allele was identified. In NC carrying ε4, AA is associated with higher risk of SCD (OR = 12.030, p = 0.029) and MCI (OR = 10.015, p = 0.044). In SCD patients without ε4, AA genotype is associated with lower risk of MCI (OR = 0.301, p = 0.006).
Conclusions
SORL1 polymorphisms influence SCD and MCI susceptibility and correlate with AD serum biomarkers. Additionally, we detected an interaction between SORL1 rs1784933 and the APOE ε4 genotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Clinical Medicine Research Institution, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
ORCID-Profile: Fanfan Meng, Tingting Zhao, Xi Yang, Hanbo Li, Jiaping Wang, Jin Liu, Tong Wang, Yi Zhu
Förderung
- National Key R&D Program of China
- Science & Technology Department of Jiangsu Province
Zitieren
APA
Meng, F., Zhao, T., Yang, X., Li, H., Wang, J., Zhu, Q., Liu, J., Wang, T., & Zhu, Y. (2026). Association of SORL1 polymorphisms and SORL1-APOE ε4 interaction with risk of subjective cognitive decline and mild cognitive impairment in the Chinese population. Journal of Alzheimer’s Disease, 111(3), 1180-1191. https://doi.org/10.1177/13872877261441644
Vancouver
Meng F, Zhao T, Yang X, Li H, Wang J, Zhu Q, et al. Association of SORL1 polymorphisms and SORL1-APOE ε4 interaction with risk of subjective cognitive decline and mild cognitive impairment in the Chinese population. Journal of Alzheimer’s Disease. 2026;111(3):1180-1191. doi:10.1177/13872877261441644
BibTeX
@article{Meng2026,
author = {Meng, Fanfan and Zhao, Tingting and Yang, Xi and Li, Hanbo and Wang, Jiaping and Zhu, Qingyun and Liu, Jin and Wang, Tong and Zhu, Yi},
title = {Association of SORL1 polymorphisms and SORL1-APOE ε4 interaction with risk of subjective cognitive decline and mild cognitive impairment in the Chinese population},
journal = {Journal of Alzheimer’s Disease},
year = {2026},
volume = {111},
number = {3},
pages = {1180--1191},
doi = {10.1177/13872877261441644}
}
EUVIMED